---
title: |
  ON THE CORRELATION BETWEEN GASTROINTESTINAL SYMPTOMS AND SITES FOR ENDOSCOPIC BIOPSIES TO DIAGNOSE GRAFT-VERSUS-HOST DISEASE
authors:
  - "Carlos Figueredo"
  - "Melissa Fazzari"
  - "Lawrence J. Brandt"
year: 2025
journal: "Clinical and Translational Gastroenterology"
doi: "10.14309/ctg.0000000000000950"
url: "https://doi.org/10.14309/ctg.0000000000000950"
lab: "berlin-bccn"
faculty:
  - "Stephan Brandt"
tags:
  - "publication"
  - "berlin-bccn"
abstract: |
  <jats:sec>
                      <jats:title>Background:</jats:title>
                      <jats:p>Gastrointestinal graft-versus-host disease (GI-GVHD) is a serious complication of hematopoietic stem cell transplantation (HSCT), with diagnosis reliant on results of endoscopic biopsy. Optimal endoscopic approaches based on symptoms remain unclear.</jats:p>
                    </jats:sec>
                    <jats:sec>
                      <jats:title>Methods:</jats:title>
                      <jats:p>We conducted a retrospective cohort study of 75 adult HSCT recipients with GVHD and GI symptoms undergoing endoscopic biopsy at Montefiore Medical Center (2015–2023). We assessed correlations between presenting upper (UGI) or lower GI (LGI) symptoms and biopsy-proven GVHD. Statistical analyses included chi-square tests, phi coefficients, and logistic regression adjusting for demographic confounders. A subgroup analysis compared the diagnostic yield of flexible sigmoidoscopy versus full colonoscopy.</jats:p>
                    </jats:sec>
                    <jats:sec>
                      <jats:title>Results:</jats:title>
                      <jats:p>
                        Biopsy positivity strongly correlated with symptom location: 89.5% of patients with UGI symptoms had positive upper GI biopsies, and 100% with LGI symptoms had positive lower GI biopsies. Chi-square tests showed significant associations between symptoms and biopsy positivity (p &lt; 0.001), with phi coefficients indicating strong correlations (
                        <jats:italic toggle="yes">r</jats:italic>
                        = 0.79 UGI;
                        <jats:italic toggle="yes">r</jats:italic>
                        = 0.82 LGI). Logistic regression confirmed symptom location as an independent predictor of biopsy results. Among 37 patients undergoing full colonoscopy, rectosigmoid biopsies showed perfect correlation with a diagnosis of GVHD (
                        <jats:italic toggle="yes">r</jats:italic>
                        = 1.0, p &lt; 0.001) when compared to other anatomic colon biopsy sites, suggesting flexible sigmoidoscopy is a cost-effective alternative for LGI symptoms.
                      </jats:p>
                    </jats:sec>
                    <jats:sec>
                      <jats:title>Conclusions:</jats:title>
                      <jats:p>Symptom-guided endoscopic evaluation in GI-GVHD yields high diagnostic accuracy. Flexible sigmoidoscopy with targeted biopsies should be considered for patients with LGI symptoms as it may reduce procedural burden and healthcare costs without compromising diagnostic yield. These findings support symptom-directed, anatomically-targeted approaches to improve patient care and resource utilization.</jats:p>
                    </jats:sec>
fulltext_available: false
fulltext_source: "none"
created: "2025-11-24T09:33:05.113277"
---

# ON THE CORRELATION BETWEEN GASTROINTESTINAL SYMPTOMS AND SITES FOR ENDOSCOPIC BIOPSIES TO DIAGNOSE GRAFT-VERSUS-HOST DISEASE

## Abstract

<jats:sec>
                    <jats:title>Background:</jats:title>
                    <jats:p>Gastrointestinal graft-versus-host disease (GI-GVHD) is a serious complication of hematopoietic stem cell transplantation (HSCT), with diagnosis reliant on results of endoscopic biopsy. Optimal endoscopic approaches based on symptoms remain unclear.</jats:p>
                  </jats:sec>
                  <jats:sec>
                    <jats:title>Methods:</jats:title>
                    <jats:p>We conducted a retrospective cohort study of 75 adult HSCT recipients with GVHD and GI symptoms undergoing endoscopic biopsy at Montefiore Medical Center (2015–2023). We assessed correlations between presenting upper (UGI) or lower GI (LGI) symptoms and biopsy-proven GVHD. Statistical analyses included chi-square tests, phi coefficients, and logistic regression adjusting for demographic confounders. A subgroup analysis compared the diagnostic yield of flexible sigmoidoscopy versus full colonoscopy.</jats:p>
                  </jats:sec>
                  <jats:sec>
                    <jats:title>Results:</jats:title>
                    <jats:p>
                      Biopsy positivity strongly correlated with symptom location: 89.5% of patients with UGI symptoms had positive upper GI biopsies, and 100% with LGI symptoms had positive lower GI biopsies. Chi-square tests showed significant associations between symptoms and biopsy positivity (p &lt; 0.001), with phi coefficients indicating strong correlations (
                      <jats:italic toggle="yes">r</jats:italic>
                      = 0.79 UGI;
                      <jats:italic toggle="yes">r</jats:italic>
                      = 0.82 LGI). Logistic regression confirmed symptom location as an independent predictor of biopsy results. Among 37 patients undergoing full colonoscopy, rectosigmoid biopsies showed perfect correlation with a diagnosis of GVHD (
                      <jats:italic toggle="yes">r</jats:italic>
                      = 1.0, p &lt; 0.001) when compared to other anatomic colon biopsy sites, suggesting flexible sigmoidoscopy is a cost-effective alternative for LGI symptoms.
                    </jats:p>
                  </jats:sec>
                  <jats:sec>
                    <jats:title>Conclusions:</jats:title>
                    <jats:p>Symptom-guided endoscopic evaluation in GI-GVHD yields high diagnostic accuracy. Flexible sigmoidoscopy with targeted biopsies should be considered for patients with LGI symptoms as it may reduce procedural burden and healthcare costs without compromising diagnostic yield. These findings support symptom-directed, anatomically-targeted approaches to improve patient care and resource utilization.</jats:p>
                  </jats:sec>

## Links

- DOI: [10.14309/ctg.0000000000000950](https://doi.org/10.14309/ctg.0000000000000950)
- URL: [Link](https://doi.org/10.14309/ctg.0000000000000950)

## Faculty

- [[berlin-bccn/faculty#stephan-brandt|Stephan Brandt]]
